Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice.
Identifieur interne : 000C88 ( Main/Exploration ); précédent : 000C87; suivant : 000C89Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice.
Auteurs : Nicolas Wentzensen [États-Unis] ; Marc Arbyn [Belgique] ; Johannes Berkhof [Pays-Bas] ; Mark Bower [Royaume-Uni] ; Karen Canfell [Australie] ; Mark Einstein [États-Unis] ; Christopher Farley [Australie] ; Joseph Monsonego [France] ; Silvia Franceschi [France]Source :
- International journal of cancer [ 1097-0215 ] ; 2017.
Descripteurs français
- KwdFr :
- MESH :
- pathogénicité : Papillomaviridae.
- usage thérapeutique : Vaccins contre les papillomavirus.
- virologie : Infections à papillomavirus, Tumeurs.
- Femelle, Humains, Infections à papillomavirus, Mâle, Tumeurs, Vaccination.
English descriptors
- KwdEn :
- MESH :
- chemical , therapeutic use : Papillomavirus Vaccines.
- pathogenicity : Papillomaviridae.
- prevention & control : Neoplasms, Papillomavirus Infections.
- virology : Neoplasms, Papillomavirus Infections.
- Female, Humans, Male, Vaccination.
Abstract
Human papillomaviruses (HPVs) are the necessary cause of most cervical cancers, a large proportion of other anogenital cancers, and a subset of oropharyngeal cancers. The knowledge about HPV has led to development of novel HPV-based prevention strategies with important impact on clinical and public health practice. Two complementary reviews have been prepared following the 2015 Eurogin Conference to evaluate how knowledge about HPV is changing practice in HPV infection and disease control through vaccination and screening. This review focuses on screening for cervical and anal cancers in increasingly vaccinated populations. The introduction of HPV vaccines a decade ago has led to reductions in HPV infections and early cancer precursors in countries with wide vaccination coverage. Despite the high efficacy of HPV vaccines, cervical cancer screening will remain important for many decades. Many healthcare systems are considering switching to primary HPV screening, which has higher sensitivity for cervical precancers and allows extending screening intervals. We describe different approaches to implementing HPV-based screening efforts in different healthcare systems with a focus in high-income countries. While the population prevalence for other anogenital cancers is too low for population-based screening, anal cancer incidence is very high in HIV-infected men who have sex with men, warranting consideration of early detection approaches. We summarize the current evidence on HPV-based prevention of anal cancers and highlight important evidence gaps.
DOI: 10.1002/ijc.30579
PubMed: 28006858
Affiliations:
- Australie, Belgique, France, Pays-Bas, Royaume-Uni, États-Unis
- Angleterre, Auvergne-Rhône-Alpes, Grand Londres, Hollande-Septentrionale, Nouvelle-Galles du Sud, Rhône-Alpes, Région de Bruxelles-Capitale, Victoria (État), Île-de-France
- Amsterdam, Bruxelles, Londres, Lyon, Melbourne, Paris, Sydney
- Université de Melbourne, Université de Sydney
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000C58
- to stream PubMed, to step Curation: 000C55
- to stream PubMed, to step Checkpoint: 000C55
- to stream Ncbi, to step Merge: 004074
- to stream Ncbi, to step Curation: 004074
- to stream Ncbi, to step Checkpoint: 004074
- to stream Main, to step Merge: 000C83
- to stream Main, to step Curation: 000C88
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice.</title><author><name sortKey="Wentzensen, Nicolas" sort="Wentzensen, Nicolas" uniqKey="Wentzensen N" first="Nicolas" last="Wentzensen">Nicolas Wentzensen</name><affiliation wicri:level="1"><nlm:affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda</wicri:regionArea><wicri:noRegion>Bethesda</wicri:noRegion></affiliation></author><author><name sortKey="Arbyn, Marc" sort="Arbyn, Marc" uniqKey="Arbyn M" first="Marc" last="Arbyn">Marc Arbyn</name><affiliation wicri:level="3"><nlm:affiliation>Unit of Cancer Epidemiology & Belgian Cancer Centre, Scientific Institute of Public Health, Brussels, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Unit of Cancer Epidemiology & Belgian Cancer Centre, Scientific Institute of Public Health, Brussels</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author><author><name sortKey="Berkhof, Johannes" sort="Berkhof, Johannes" uniqKey="Berkhof J" first="Johannes" last="Berkhof">Johannes Berkhof</name><affiliation wicri:level="3"><nlm:affiliation>Department of Clinical Epidemiology and Biostatistics, VU University Medical Centre, Amsterdam, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Clinical Epidemiology and Biostatistics, VU University Medical Centre, Amsterdam</wicri:regionArea><placeName><settlement type="city">Amsterdam</settlement><region nuts="2" type="province">Hollande-Septentrionale</region></placeName></affiliation></author><author><name sortKey="Bower, Mark" sort="Bower, Mark" uniqKey="Bower M" first="Mark" last="Bower">Mark Bower</name><affiliation wicri:level="3"><nlm:affiliation>Department of Surgery & Cancer, Faculty of Medicine, Imperial College, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Surgery & Cancer, Faculty of Medicine, Imperial College, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Canfell, Karen" sort="Canfell, Karen" uniqKey="Canfell K" first="Karen" last="Canfell">Karen Canfell</name><affiliation wicri:level="4"><nlm:affiliation>Cancer Research Division, Cancer Council NSW, Sydney, NSW, Australia; School of Public Health, University of Sydney, Sydney, NSW, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Cancer Research Division, Cancer Council NSW, Sydney, NSW, Australia; School of Public Health, University of Sydney, Sydney, NSW</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Einstein, Mark" sort="Einstein, Mark" uniqKey="Einstein M" first="Mark" last="Einstein">Mark Einstein</name><affiliation wicri:level="1"><nlm:affiliation>Department of OB/GYN & Women's Health, Rutgers New Jersey Medical School, Newark, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of OB/GYN & Women's Health, Rutgers New Jersey Medical School, Newark</wicri:regionArea><wicri:noRegion>Newark</wicri:noRegion></affiliation></author><author><name sortKey="Farley, Christopher" sort="Farley, Christopher" uniqKey="Farley C" first="Christopher" last="Farley">Christopher Farley</name><affiliation wicri:level="4"><nlm:affiliation>Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Melbourne School of Population and Global Health, University of Melbourne, Melbourne</wicri:regionArea><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region><settlement type="city">Melbourne</settlement></placeName><orgName type="university">Université de Melbourne</orgName></affiliation></author><author><name sortKey="Monsonego, Joseph" sort="Monsonego, Joseph" uniqKey="Monsonego J" first="Joseph" last="Monsonego">Joseph Monsonego</name><affiliation wicri:level="3"><nlm:affiliation>Institut du Col, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Institut du Col, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Franceschi, Silvia" sort="Franceschi, Silvia" uniqKey="Franceschi S" first="Silvia" last="Franceschi">Silvia Franceschi</name><affiliation wicri:level="3"><nlm:affiliation>International Agency for Research on Cancer, Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>International Agency for Research on Cancer, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28006858</idno><idno type="pmid">28006858</idno><idno type="doi">10.1002/ijc.30579</idno><idno type="wicri:Area/PubMed/Corpus">000C58</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000C58</idno><idno type="wicri:Area/PubMed/Curation">000C55</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000C55</idno><idno type="wicri:Area/PubMed/Checkpoint">000C55</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000C55</idno><idno type="wicri:Area/Ncbi/Merge">004074</idno><idno type="wicri:Area/Ncbi/Curation">004074</idno><idno type="wicri:Area/Ncbi/Checkpoint">004074</idno><idno type="wicri:Area/Main/Merge">000C83</idno><idno type="wicri:Area/Main/Curation">000C88</idno><idno type="wicri:Area/Main/Exploration">000C88</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice.</title><author><name sortKey="Wentzensen, Nicolas" sort="Wentzensen, Nicolas" uniqKey="Wentzensen N" first="Nicolas" last="Wentzensen">Nicolas Wentzensen</name><affiliation wicri:level="1"><nlm:affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda</wicri:regionArea><wicri:noRegion>Bethesda</wicri:noRegion></affiliation></author><author><name sortKey="Arbyn, Marc" sort="Arbyn, Marc" uniqKey="Arbyn M" first="Marc" last="Arbyn">Marc Arbyn</name><affiliation wicri:level="3"><nlm:affiliation>Unit of Cancer Epidemiology & Belgian Cancer Centre, Scientific Institute of Public Health, Brussels, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Unit of Cancer Epidemiology & Belgian Cancer Centre, Scientific Institute of Public Health, Brussels</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author><author><name sortKey="Berkhof, Johannes" sort="Berkhof, Johannes" uniqKey="Berkhof J" first="Johannes" last="Berkhof">Johannes Berkhof</name><affiliation wicri:level="3"><nlm:affiliation>Department of Clinical Epidemiology and Biostatistics, VU University Medical Centre, Amsterdam, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Clinical Epidemiology and Biostatistics, VU University Medical Centre, Amsterdam</wicri:regionArea><placeName><settlement type="city">Amsterdam</settlement><region nuts="2" type="province">Hollande-Septentrionale</region></placeName></affiliation></author><author><name sortKey="Bower, Mark" sort="Bower, Mark" uniqKey="Bower M" first="Mark" last="Bower">Mark Bower</name><affiliation wicri:level="3"><nlm:affiliation>Department of Surgery & Cancer, Faculty of Medicine, Imperial College, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Surgery & Cancer, Faculty of Medicine, Imperial College, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Canfell, Karen" sort="Canfell, Karen" uniqKey="Canfell K" first="Karen" last="Canfell">Karen Canfell</name><affiliation wicri:level="4"><nlm:affiliation>Cancer Research Division, Cancer Council NSW, Sydney, NSW, Australia; School of Public Health, University of Sydney, Sydney, NSW, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Cancer Research Division, Cancer Council NSW, Sydney, NSW, Australia; School of Public Health, University of Sydney, Sydney, NSW</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Einstein, Mark" sort="Einstein, Mark" uniqKey="Einstein M" first="Mark" last="Einstein">Mark Einstein</name><affiliation wicri:level="1"><nlm:affiliation>Department of OB/GYN & Women's Health, Rutgers New Jersey Medical School, Newark, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of OB/GYN & Women's Health, Rutgers New Jersey Medical School, Newark</wicri:regionArea><wicri:noRegion>Newark</wicri:noRegion></affiliation></author><author><name sortKey="Farley, Christopher" sort="Farley, Christopher" uniqKey="Farley C" first="Christopher" last="Farley">Christopher Farley</name><affiliation wicri:level="4"><nlm:affiliation>Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Melbourne School of Population and Global Health, University of Melbourne, Melbourne</wicri:regionArea><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region><settlement type="city">Melbourne</settlement></placeName><orgName type="university">Université de Melbourne</orgName></affiliation></author><author><name sortKey="Monsonego, Joseph" sort="Monsonego, Joseph" uniqKey="Monsonego J" first="Joseph" last="Monsonego">Joseph Monsonego</name><affiliation wicri:level="3"><nlm:affiliation>Institut du Col, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Institut du Col, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Franceschi, Silvia" sort="Franceschi, Silvia" uniqKey="Franceschi S" first="Silvia" last="Franceschi">Silvia Franceschi</name><affiliation wicri:level="3"><nlm:affiliation>International Agency for Research on Cancer, Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>International Agency for Research on Cancer, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author></analytic><series><title level="j">International journal of cancer</title><idno type="eISSN">1097-0215</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Female</term><term>Humans</term><term>Male</term><term>Neoplasms (prevention & control)</term><term>Neoplasms (virology)</term><term>Papillomaviridae (pathogenicity)</term><term>Papillomavirus Infections (prevention & control)</term><term>Papillomavirus Infections (virology)</term><term>Papillomavirus Vaccines (therapeutic use)</term><term>Vaccination</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Femelle</term><term>Humains</term><term>Infections à papillomavirus ()</term><term>Infections à papillomavirus (virologie)</term><term>Mâle</term><term>Papillomaviridae (pathogénicité)</term><term>Tumeurs ()</term><term>Tumeurs (virologie)</term><term>Vaccination</term><term>Vaccins contre les papillomavirus (usage thérapeutique)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Papillomavirus Vaccines</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Papillomaviridae</term></keywords><keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Papillomaviridae</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Neoplasms</term><term>Papillomavirus Infections</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Vaccins contre les papillomavirus</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Infections à papillomavirus</term><term>Tumeurs</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Neoplasms</term><term>Papillomavirus Infections</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Female</term><term>Humans</term><term>Male</term><term>Vaccination</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Femelle</term><term>Humains</term><term>Infections à papillomavirus</term><term>Mâle</term><term>Tumeurs</term><term>Vaccination</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Human papillomaviruses (HPVs) are the necessary cause of most cervical cancers, a large proportion of other anogenital cancers, and a subset of oropharyngeal cancers. The knowledge about HPV has led to development of novel HPV-based prevention strategies with important impact on clinical and public health practice. Two complementary reviews have been prepared following the 2015 Eurogin Conference to evaluate how knowledge about HPV is changing practice in HPV infection and disease control through vaccination and screening. This review focuses on screening for cervical and anal cancers in increasingly vaccinated populations. The introduction of HPV vaccines a decade ago has led to reductions in HPV infections and early cancer precursors in countries with wide vaccination coverage. Despite the high efficacy of HPV vaccines, cervical cancer screening will remain important for many decades. Many healthcare systems are considering switching to primary HPV screening, which has higher sensitivity for cervical precancers and allows extending screening intervals. We describe different approaches to implementing HPV-based screening efforts in different healthcare systems with a focus in high-income countries. While the population prevalence for other anogenital cancers is too low for population-based screening, anal cancer incidence is very high in HIV-infected men who have sex with men, warranting consideration of early detection approaches. We summarize the current evidence on HPV-based prevention of anal cancers and highlight important evidence gaps.</div></front></TEI><affiliations><list><country><li>Australie</li><li>Belgique</li><li>France</li><li>Pays-Bas</li><li>Royaume-Uni</li><li>États-Unis</li></country><region><li>Angleterre</li><li>Auvergne-Rhône-Alpes</li><li>Grand Londres</li><li>Hollande-Septentrionale</li><li>Nouvelle-Galles du Sud</li><li>Rhône-Alpes</li><li>Région de Bruxelles-Capitale</li><li>Victoria (État)</li><li>Île-de-France</li></region><settlement><li>Amsterdam</li><li>Bruxelles</li><li>Londres</li><li>Lyon</li><li>Melbourne</li><li>Paris</li><li>Sydney</li></settlement><orgName><li>Université de Melbourne</li><li>Université de Sydney</li></orgName></list><tree><country name="États-Unis"><noRegion><name sortKey="Wentzensen, Nicolas" sort="Wentzensen, Nicolas" uniqKey="Wentzensen N" first="Nicolas" last="Wentzensen">Nicolas Wentzensen</name></noRegion><name sortKey="Einstein, Mark" sort="Einstein, Mark" uniqKey="Einstein M" first="Mark" last="Einstein">Mark Einstein</name></country><country name="Belgique"><region name="Région de Bruxelles-Capitale"><name sortKey="Arbyn, Marc" sort="Arbyn, Marc" uniqKey="Arbyn M" first="Marc" last="Arbyn">Marc Arbyn</name></region></country><country name="Pays-Bas"><region name="Hollande-Septentrionale"><name sortKey="Berkhof, Johannes" sort="Berkhof, Johannes" uniqKey="Berkhof J" first="Johannes" last="Berkhof">Johannes Berkhof</name></region></country><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Bower, Mark" sort="Bower, Mark" uniqKey="Bower M" first="Mark" last="Bower">Mark Bower</name></region></country><country name="Australie"><region name="Nouvelle-Galles du Sud"><name sortKey="Canfell, Karen" sort="Canfell, Karen" uniqKey="Canfell K" first="Karen" last="Canfell">Karen Canfell</name></region><name sortKey="Farley, Christopher" sort="Farley, Christopher" uniqKey="Farley C" first="Christopher" last="Farley">Christopher Farley</name></country><country name="France"><region name="Île-de-France"><name sortKey="Monsonego, Joseph" sort="Monsonego, Joseph" uniqKey="Monsonego J" first="Joseph" last="Monsonego">Joseph Monsonego</name></region><name sortKey="Franceschi, Silvia" sort="Franceschi, Silvia" uniqKey="Franceschi S" first="Silvia" last="Franceschi">Silvia Franceschi</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C88 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000C88 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:28006858
|texte= Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:28006858" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |